SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
569Wednesday April 10, 7:32 am Eastern Time Press Release SOURCE: Celgene CorporatiMiljenko Zuanic-4/10/2002
568Advances in Kinase Inhibitors to Highlight Day 1 at Inflammation in Drug Discovekeokalani'nui-3/27/2002
567Before Novartis deal VRTX reported progress with c-jun N-terminal protein kinaseMiljenko Zuanic-3/26/2002
566MZ, This article on how VRTX uses NMR in its drug discovery process may containtuck-3/26/2002
565David versus Goliath (in past): Tuesday February 5, 8:08 am Eastern Time Press Miljenko Zuanic-2/5/2002
564VRTX was very high on list in ‘99/'00, after Novartis deal. However, and as Miljenko Zuanic-2/3/2002
563Thanks for the reply - I got a subscription to the Gilder biotech newsletter forMammon-2/3/2002
562How many of us are there? Stocks that you put into a contest portfolio need notscaram(o)uche-2/2/2002
561Why didn't any of you all choose VRTX for the 2002 stockpicking contest?Mammon-2/2/2002
560From AAAAI 58th Annual Meeting 157 Safety and Pharmacokinetics of an Oral p38 MMiljenko Zuanic-1/18/2002
559>> Caspase inhibitor for sepsis? << Not exactly moving upstream. Ascaram(o)uche-1/9/2002
558Caspase inhibitor for sepsis? Tuesday January 8, 8:04 am Eastern Time Press RelMiljenko Zuanic-1/8/2002
557biz.yahoo.com Tuesday January 8, 8:04 am Eastern Time Vertex Pharmaceuticals Ptom pope-1/8/2002
556Only optimism of the type usually shown in an investor forum, except I thought ikeokalani'nui-1/7/2002
555Wilder, RIGL have done considerable amount of work on serine proteases. Any indMiljenko Zuanic-1/7/2002
554Rigel's Hep-C program looking to be published in Spring, per H&Q conf. keokalani'nui-1/7/2002
553Hepatitis C Drug Said to Be Created [NYT] nytimes.com January 7, 2002 By ANDRDoc Bones-1/6/2002
552What is going on with *eight* clinical programs? Thursday January 3, 4:00 pm EaMiljenko Zuanic-1/3/2002
551(This was a spinoff from vrtx) Wednesday December 26, 9:01 am Eastern Time Presrkrw-12/26/2001
550This is nor true IL-1 inhibitor: ncbi.nlm.nih.gov But, what in the hell AventisMiljenko Zuanic-12/18/2001
549Give me a brake. I am hearing this stories for last two years. :( MiljenkoMiljenko Zuanic-11/13/2001
548Great story on VRTX in FORBES today,.... forbes.comPeter S. Maroulis-11/13/2001
547SOURCE: Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Announces theMiljenko Zuanic-10/29/2001
546Blockade of IL-1-beta-Converting Enzyme Decreases Intestinal Inflammation -----Miljenko Zuanic-10/25/2001
545Vertex Pharmaceuticals Reports Third Quarter 2001 Financial Results CAMBRIDGE, nigel bates-10/24/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):